Integra LifeSciences Holdings Corporation

IART · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$7$68$181$169
Dep. & Amort.$141$124$118$120
Deferred Tax-$21-$12-$5-$3
Stock-Based Comp.$24$20$28$36
Change in WC-$31-$82-$39$18
Other Non-Cash$23$22-$18-$28
Operating Cash Flow$129$140$264$312
Investing Activities
PP&E Inv.-$104-$67-$47-$48
Net Acquisitions-$278$0-$28-$113
Inv. Purchases-$49-$33-$5$0
Inv. Sales/Matur.$55$5$5$0
Other Inv. Act.-$14$0$16-$0
Investing Cash Flow-$391-$94-$59-$161
Financing Activities
Debt Repay.$299$55-$108-$100
Stock Issued$0$0$0$0
Stock Repurch.-$52-$275-$125$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$9-$9-$19$2
Financing Cash Flow$238-$230-$252-$98
Forex Effect-$6$4-$11-$9
Net Chg. in Cash-$30-$180-$57$43
Supplemental Information
Beg. Cash$276$457$513$470
End Cash$246$276$457$513
Free Cash Flow$25$73$217$264
Integra LifeSciences Holdings Corporation (IART) Financial Statements & Key Stats | AlphaPilot